People Pill
Definition of 'People Pill'A defensive strategy to ward off a hostile takeover. The target company's management team threatens that, in the event of a takeover, the entire team will resign. The purpose of a people pill is to discourage the acquiring company from completing the takeover, by introducing the possibility of having to put together an entirely new management team. This strategy is only effective if the acquiring company wants to keep the existing management. |
|
Investopedia explains 'People Pill'The first use of the people pill anti-takeover strategy is attributed to a food company called the Borden Corporation. In 1989, the company's board of directors approved a people pill that Borden could use to demand that an acquiring company pay a fair value for the company's shares and that it not fire or demote any of Borden's existing managers. The people pill strategy is a variation of the poison pill defense. Other takeover defenses include staggered boards, golden parachutes and shareholder rights plans. |
Related Definitions
Articles Of Interest
-
Mergers And Acquisitions: Understanding Takeovers
In the dramatic world of M&As, battleground terms meld with bizarre metaphors to form the language of the game. -
The Merger - What To Do When Companies Converge
Learn how to invest in companies before, during and after they join together. -
Trade Takeover Stocks With Merger Arbitrage
This high-risk strategy attempts to profit from price discrepancies that arise during acquisitions. -
Trademarks Of A Takeover Target
These tips can lead you to little companies with big prospects. -
Pinpoint Takeovers First
Use these seven steps to discover a takeover before the rest of the market catches on. -
Corporate Takeover Defense: A Shareholder's Perspective
Find out the strategies corporations use to protect themselves from unwanted acquisitions. -
What Determines Your Cost Basis?
In any transaction between a buyer and seller, the initial price paid in an exchange for a product or service will qualify as the cost basis. When it comes to securities and related financial ... -
Valeant Eyes Bausch & Lomb
Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was buying Bausch & Lomb for $8.7 billion making it a global leader in ... -
Sears' Losses Widen In Q1 - Time To Merge With JC Penney?
Sears Holdings delivered another brutal quarter May 23. CEO and majority owner Edward Lampert has his hands full trying to revive a truly broken department store. Rumor has Neiman Marcus and ... -
Arbitrage Squeezes Profit From Market Inefficiency
This influential strategy capitalizes on the relationship between price and liquidity.
Free Annual Reports